期刊
ENDOCRINOLOGY
卷 163, 期 7, 页码 -出版社
ENDOCRINE SOC
DOI: 10.1210/endocr/bqac067
关键词
immunometabolism; systemic metabolism; lupus; autoimmunity
资金
- National Institutes of Health [R01 AI128901]
There is a high prevalence of metabolic syndrome (MetS) in systemic lupus erythematosus (SLE) patients, which is likely caused by autoimmune pathogenesis. The impact of MetS on the immune system and disease manifestations in SLE patients is not well understood. Immune cell metabolism is altered and overactivated in SLE patients.
A high prevalence of metabolic syndrome (MetS) has been reported in multiple cohorts of systemic lupus erythematosus (SLE) patients, most likely as one of the consequences of autoimmune pathogenesis. Although MetS has been associated with inflammation, its consequences on the lupus immune system and on disease manifestations are largely unknown. The metabolism of immune cells is altered and overactivated in mouse models as well as in patients with SLE, and several metabolic inhibitors have shown therapeutic benefits. Here we review recent studies reporting these findings, as well as the effect of dietary interventions in clinical and preclinical studies of SLE. We also explore potential causal links between systemic and immunometabolism in the context of lupus, and the knowledge gap that needs to be addressed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据